Cargando…

Comparison of the Mortality Prediction Value of Soluble Urokinase Plasminogen Activator Receptor (suPAR) in COVID-19 and Sepsis

In the last years, biomarkers of infection, such as the soluble urokinase plasminogen activator receptor (suPAR), have been extensively studied as potential diagnostic and prognostic biomarkers in the intensive care unit (ICU). In this study, we investigated whether this biomarker can be used in COV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vassiliou, Alice G., Zacharis, Alexandros, Vrettou, Charikleia S., Keskinidou, Chrysi, Jahaj, Edison, Mastora, Zafeiria, Orfanos, Stylianos E., Dimopoulou, Ioanna, Kotanidou, Anastasia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140363/ https://www.ncbi.nlm.nih.gov/pubmed/35626416 http://dx.doi.org/10.3390/diagnostics12051261

Ejemplares similares

Evaluating the Role of the Interleukin-23/17 Axis in Critically Ill COVID-19 Patients
por: Jahaj, Edison, et al.
Publicado: (2021)

Prognostic Value of HIF-1α-Induced Genes in Sepsis/Septic Shock
por: Lotsios, Nikolaos S., et al.
Publicado: (2023)

Investigation of Serum Endocan Levels and Age in Critical Inflammatory Conditions
por: Keskinidou, Chrysi, et al.
Publicado: (2023)

Low Admission Immunoglobulin G Levels Predict Poor Outcome in Patients with Mild-to-Critical COVID-19: A Prospective, Single-Center Study
por: Vrettou, Charikleia S., et al.
Publicado: (2021)

Endothelial, Immunothrombotic, and Inflammatory Biomarkers in the Risk of Mortality in Critically Ill COVID-19 Patients: The Role of Dexamethasone
por: Keskinidou, Chrysi, et al.
Publicado: (2021)

Endotheliopathy in Acute COVID-19 and Long COVID
por: Vassiliou, Alice G., et al.
Publicado: (2023)

Lactate and Lactate-to-Pyruvate Ratio in Critically Ill COVID-19 Patients: A Pilot Study
por: Vassiliou, Alice G., et al.
Publicado: (2022)

Changes in Cortisol Secretion and Corticosteroid Receptors in COVID-19 and Non COVID-19 Critically Ill Patients with Sepsis/Septic Shock and Scope for Treatment
por: Ilias, Ioannis, et al.
Publicado: (2023)

Soluble Angiotensin Converting Enzyme 2 (ACE2) Is Upregulated and Soluble Endothelial Nitric Oxide Synthase (eNOS) Is Downregulated in COVID-19-induced Acute Respiratory Distress Syndrome (ARDS)
por: Vassiliou, Alice G., et al.
Publicado: (2021)

Prognostic Value of Bone Formation and Resorption Proteins in Heterotopic Ossification in Critically-Ill Patients. a Single-Centre Study
por: Vassiliou, Alice Georgia, et al.
Publicado: (2021)

Lactate Kinetics Reflect Organ Dysfunction and Are Associated with Adverse Outcomes in Intensive Care Unit Patients with COVID-19 Pneumonia: Preliminary Results from a GREEK Single-Centre Study
por: Vassiliou, Alice G., et al.
Publicado: (2020)

ICU Admission Levels of Endothelial Biomarkers as Predictors of Mortality in Critically Ill COVID-19 Patients
por: Vassiliou, Alice G., et al.
Publicado: (2021)

Serum Neutrophil Gelatinase-Associated Lipocalin (NGAL) Could Provide Better Accuracy Than Creatinine in Predicting Acute Kidney Injury Development in Critically Ill Patients
por: Jahaj, Edison, et al.
Publicado: (2021)

Autotaxin Has a Negative Role in Systemic Inflammation
por: Nikitopoulou, Ioanna, et al.
Publicado: (2022)

Mechanistic Understanding of Lung Inflammation: Recent Advances and Emerging Techniques
por: Keskinidou, Chrysi, et al.
Publicado: (2022)

Kinetics of the soluble urokinase plasminogen activator receptor (suPAR) in cirrhosis
por: Garnæs, Emilie, et al.
Publicado: (2019)

Persistent Endothelial Lung Damage and Impaired Diffusion Capacity in Long COVID
por: Asimakos, Andreas T., et al.
Publicado: (2023)

Soluble urokinase plasminogen activator receptor (suPAR) in the emergency department: An update
por: Velissaris, Dimitrios, et al.
Publicado: (2022)

Vitamin D deficiency correlates with a reduced number of natural killer cells in intensive care unit (ICU) and non-ICU patients with COVID-19 pneumonia
por: Vassiliou, Alice G., et al.
Publicado: (2021)

Glucocorticoid and mineralocorticoid receptor expression in critical illness: A narrative review
por: Vassiliou, Alice G, et al.
Publicado: (2021)

The Interplay between Aquaporin-1 and the Hypoxia-Inducible Factor 1α in a Lipopolysaccharide-Induced Lung Injury Model in Human Pulmonary Microvascular Endothelial Cells
por: Keskinidou, Chrysi, et al.
Publicado: (2022)

Vitamin D in infectious complications in critically ill patients with or without COVID-19
por: Vassiliou, Alice G., et al.
Publicado: (2021)

Increased Glucocorticoid Receptor Alpha Expression and Signaling in Critically Ill Coronavirus Disease 2019 Patients*
por: Vassiliou, Alice G., et al.
Publicado: (2021)

Post-Intensive Care Syndrome in Survivors from Critical Illness including COVID-19 Patients: A Narrative Review
por: Vrettou, Charikleia S., et al.
Publicado: (2022)

Family Burden of ICU Survivors and Correlations with Patient Quality of Life and Psychometric Scores – A Pilot Study
por: Mantziou, Vassiliki, et al.
Publicado: (2022)

Serum soluble urokinase plasminogen activator receptor (suPAR) in adults with growth hormone deficiency
por: Höybye, Charlotte, et al.
Publicado: (2019)

Soluble Urokinase Plasminogen Activator Receptor (suPAR) Concentrations Are Elevated in Patients with Neuroendocrine Malignancies
por: Özdirik, Burcin, et al.
Publicado: (2020)

Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation
por: Rasmussen, Line Jee Hartmann, et al.
Publicado: (2021)

Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Autoimmune Rheumatic and Non Rheumatic Diseases
por: Manfredi, Mariangela, et al.
Publicado: (2023)

Low 25-Hydroxyvitamin D Levels on Admission to the Intensive Care Unit May Predispose COVID-19 Pneumonia Patients to a Higher 28-Day Mortality Risk: A Pilot Study on a Greek ICU Cohort
por: Vassiliou, Alice G., et al.
Publicado: (2020)

Increased Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels in Plasma of Suicide Attempters
por: Ventorp, Filip, et al.
Publicado: (2015)

Quality of Life, Depression, and Anxiety in Survivors of Critical Illness from a Greek ICU. A Prospective Observational Study
por: Vrettou, Charikleia S., et al.
Publicado: (2021)

Induced expression and functional effects of aquaporin-1 in human leukocytes in sepsis
por: Vassiliou, Alice G, et al.
Publicado: (2013)

The Clinical Value of Soluble Urokinase Plasminogen Activator Receptor (suPAR) Levels in Autoimmune Connective Tissue Disorders
por: Vasarhelyi, Barna, et al.
Publicado: (2016)

Soluble Urokinase Plasminogen Activator Receptor (suPAR) and All-Cause and Cardiovascular Mortality in Diverse Hemodialysis Patients
por: Torino, Claudia, et al.
Publicado: (2018)

Evaluation of soluble urokinase-type plasminogen activator receptor (suPAR) quick test for triage in the emergency department
por: Kumar, Pratyush, et al.
Publicado: (2019)

Relationship Between Soluble Urokinase Plasminogen Activator Receptor (suPAR) and Disease Outcome in Adult-Onset Asthma
por: Niemelä, Taito, et al.
Publicado: (2022)

Soluble urokinase Plasminogen Activator Receptor (suPAR) levels are predictive of COVID-19 severity: an Italian experience
por: Infantino, Maria, et al.
Publicado: (2022)

Serum Levels of Urokinase Plasminogen Activator Receptor (suPAR) Discriminate Moderate Uncontrolled from Severe Asthma
por: Kotsiou, Ourania S., et al.
Publicado: (2022)

Relationship of Circulating Soluble Urokinase Plasminogen Activator Receptor (suPAR) Levels to Disease Control in Asthma and Asthmatic Pregnancy
por: Ivancsó, István, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_md7u42fqirrfk0afdpb0gr97sd